Newsroom

Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders

Takeda Expands Moderna’s COVID-19 Vaccine Supply in Japan in Partnership with the Japanese Government

Takeda Announces the Submission of its Corporate Governance Report to the Tokyo Stock Exchange

New Data from the Phase 3 HELP Study^™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO^® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

Notice Concerning Issuance of New Shares under the Long-Term Incentive Plan for Company Group Employees Overseas